Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42291020

Ali Taghizadeh Yadegari; Elnaz Khani; Hila Asham; Hoda Afsharirad; Hossein Bannazadeh-Baghi; Meysam Zarezadeh; Taher Entezari-Maleki

Jun 16, 2026